N -Acetylcysteine alleviates gut dysbiosis and glucose metabolic disorder in high-fat diet-fed mice

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

N-Acetylcysteine (NAC), an antioxidative reagent for clinical diseases, shows potential in the treatment of diabetes and other metabolic diseases. However, it is unknown how NAC modulates the gut microbiota of mice with metabolic syndrome. The aim of the present study was to demonstrate the preventive effect of NAC on intestinal dysbiosis and glucose metabolic disorder.

Related collections

Most cited references 23

Record: found
Abstract: found
Article: not found

How glycan metabolism shapes the human gut microbiota.

Nicole M. Koropatkin, Elizabeth A Cameron, Eric C. Martens (2012)

Symbiotic microorganisms that reside in the human intestine are adept at foraging glycans and polysaccharides, including those in dietary plants (starch, hemicellulose and pectin), animal-derived cartilage and tissue (glycosaminoglycans and N-linked glycans), and host mucus (O-linked glycans). Fluctuations in the abundance of dietary and endogenous glycans, combined with the immense chemical variation among these molecules, create a dynamic and heterogeneous environment in which gut microorganisms proliferate. In this Review, we describe how glycans shape the composition of the gut microbiota over various periods of time, the mechanisms by which individual microorganisms degrade these glycans, and potential opportunities to intentionally influence this ecosystem for better health and nutrition.

0 comments Cited 516 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

Health benefits of fermented foods: microbiota and beyond.

Maria L. Marco, Dustin Heeney, Sylvie Binda … (2017)

Fermented foods and beverages were among the first processed food products consumed by humans. The production of foods such as yogurt and cultured milk, wine and beer, sauerkraut and kimchi, and fermented sausage were initially valued because of their improved shelf life, safety, and organoleptic properties. It is increasingly understood that fermented foods can also have enhanced nutritional and functional properties due to transformation of substrates and formation of bioactive or bioavailable end-products. Many fermented foods also contain living microorganisms of which some are genetically similar to strains used as probiotics. Although only a limited number of clinical studies on fermented foods have been performed, there is evidence that these foods provide health benefits well-beyond the starting food materials.

0 comments Cited 372 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: found

Is Open Access

Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity

Amandine Everard, Vladimir Lazarevic, Nadia Gaïa … (2014)

The gut microbiota is involved in metabolic and immune disorders associated with obesity and type 2 diabetes. We previously demonstrated that prebiotic treatment may significantly improve host health by modulating bacterial species related to the improvement of gut endocrine, barrier and immune functions. An analysis of the gut metagenome is needed to determine which bacterial functions and taxa are responsible for beneficial microbiota–host interactions upon nutritional intervention. We subjected mice to prebiotic (Pre) treatment under physiological (control diet: CT) and pathological conditions (high-fat diet: HFD) for 8 weeks and investigated the production of intestinal antimicrobial peptides and the gut microbiome. HFD feeding significantly decreased the expression of regenerating islet-derived 3-gamma (Reg3g) and phospholipase A2 group-II (PLA2g2) in the jejunum. Prebiotic treatment increased Reg3g expression (by ∼50-fold) and improved intestinal homeostasis as suggested by the increase in the expression of intectin, a key protein involved in intestinal epithelial cell turnover. Deep metagenomic sequencing analysis revealed that HFD and prebiotic treatment significantly affected the gut microbiome at different taxonomic levels. Functional analyses based on the occurrence of clusters of orthologous groups (COGs) of proteins also revealed distinct profiles for the HFD, Pre, HFD-Pre and CT groups. Finally, the gut microbiota modulations induced by prebiotics counteracted HFD-induced inflammation and related metabolic disorders. Thus, we identified novel putative taxa and metabolic functions that may contribute to the development of or protection against the metabolic alterations observed during HFD feeding and HFD-Pre feeding.

0 comments Cited 252 times – based on 0 reviews      Review now

Bookmark

All references

Author and article information

Journal

Title: Journal of Diabetes

Abbreviated Title: Journal of Diabetes

Publisher: Wiley

ISSN: 17530393

Publication date Created: January 2019

Publication date (Print): January 2019

Publication date (Electronic): July 04 2018

Volume: 11

Issue: 1

Pages: 32-45

Affiliations

[1 ]Liaoning Provincial Key Laboratory of Carbohydrates, Dalian Institute of Chemical Physics; Chinese Academy of Sciences; Dalian China

[2 ]University of Chinese Academy of Sciences; Beijing China

[3 ]State Key Laboratory of Biochemical Engineering and Key Laboratory of Biopharmaceutical Production & Formulation Engineering, Institute of Process Engineering; Chinese Academy of Sciences; Beijing China

[4 ]Zhengzhou Institute of Emerging Industrial Technology; Zhengzhou China